Augmedix, Inc.
Augmedix, Inc. (AUGX) Stock Overview
Explore Augmedix, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
115.9M
P/E Ratio
-5.38
EPS (TTM)
$-0.47
ROE
-1.55%
AUGX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Augmedix, Inc. (AUGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $3.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.38 and a market capitalization of 115.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.